Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?

dc.contributor.authorOwoicho, O.
dc.contributor.authorTapela, K.
dc.contributor.authorZune, A.L.D.
dc.contributor.authorNghochuzie, N.N.
dc.contributor.authorIsawumi, A.
dc.contributor.authorMosi, L.
dc.date.accessioned2021-11-15T14:06:38Z
dc.date.available2021-11-15T14:06:38Z
dc.date.issued2021
dc.descriptionRESEARCH ARTICLEen_US
dc.description.abstractIn the absence of potent antimicrobial agents, it is estimated that bacterial infections could cause millions of deaths. The emergence of COVID-19, its complex pathophysiology and the high propensity of patients to coinfections has resulted in therapeutic regimes that use a cocktail of antibiotics for disease management. Suboptimal antimicrobial stewardship in this era and the slow pace of drug discovery could result in large-scale drug resistance, narrowing future antimicrobial therapeutics. Thus, judicious use of current antimicrobials is imperative to keep up with existing and emerging infectious pathogens. Here, we provide insights into the potential implications of suboptimal antimicrobial stewardship, resulting from the emergence of COVID-19, on the spread of antimicrobial resistanceen_US
dc.identifier.citation10.2217/fmb-2021-0008en_US
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/37131
dc.language.isoenen_US
dc.publisherFUTURE MICROBIOLOGYen_US
dc.subjectantimicrobial resistanceen_US
dc.subjectcoronavirusen_US
dc.subjectCOVID-19en_US
dc.subjecthand sanitizationen_US
dc.subjecthand washingen_US
dc.subjectSARS-CoV-2en_US
dc.titleSuboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?en_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Suboptimal antimicrobial stewardship in the.pdf
Size:
1.26 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: